<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="etha" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">etha</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">SCN9A</italic>-Related Inherited Erythromelalgia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hisama</surname>
            <given-names>Fuki M</given-names>
          </name>
          <degrees>MD</degrees>
          <email>fmh2@u.washington.edu</email>
          <aff>Division of Genetics<break/>Department of Medicine<break/>University of Washington<break/>Seattle, Washington</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dib-Hajj</surname>
            <given-names>Sulayman D</given-names>
          </name>
          <degrees>PhD</degrees>
          <email>sulayman.dib-hajj@yale.edu</email>
          <aff>Senior Research Scientist, Center for Neuroscience and Regeneration Research<break/>Department of Neurology<break/>Yale University School of Medicine<break/>New Haven, Connecticut</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Waxman</surname>
            <given-names>Stephen G</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <email>stephen.waxman@yale.edu</email>
          <aff>Professor and Chair, Center for Neuroscience and Regeneration Research<break/>Department of Neurology<break/>Yale University School of Medicine<break/>New Haven, Connecticut</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2006-05-06" date-type="created">
          <day>6</day>
          <month>5</month>
          <year>2006</year>
        </date>
        <date iso-8601-date="2013-08-15" date-type="updated">
          <day>15</day>
          <month>8</month>
          <year>2013</year>
        </date>
        <date iso-8601-date="2008-09-25" date-type="revised">
          <day>25</day>
          <month>9</month>
          <year>2008</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="scn8a-ee" document-type="chapter"><italic toggle="yes">SCN8A</italic>-Related Epilepsy with Encephalopathy</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="lwd" document-type="chapter">SHOX Deficiency Disorders</related-object>
      <abstract id="etha.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">SCN9A</italic>-related inherited erythromelalgia (<italic toggle="yes">SCN9A</italic>-related IEM) is characterized by recurrent attacks of bilateral and symmetric intense pain, redness, warmth, and swelling involving the feet and, less frequently, the hands. <italic toggle="yes">SCN9A</italic>-related IEM is not associated with an organic disease. Manifestations may vary within a family. Onset is usually in childhood or adolescence but has been recognized in infants and adults. At onset, episodes are triggered by warmth; other precipitating factors include: exercise, tight shoes, wearing socks, alcohol, spicy foods, and other vasodilating agents. In advanced disease, symptoms may occur many times a day or become constant. Some individuals have allodynia (pain evoked by a normally innocuous stimulus) and hyperalgesia (increased sensitivity to a painful stimulus). Episodes may be disabling, interfere with sleep, and severely limit normal activities such as walking, participation in sports, wearing socks and shoes, and attending school or going to work.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of <italic toggle="yes">SCN9A</italic>-related IEM is made on clinical grounds. Pathogenic variants in <italic toggle="yes">SCN9A</italic> encoding the sodium channel protein Na<sub>v</sub>1.7 subunit are known to cause IEM; pathogenic variants in additional genes may also be associated with IEM.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Pain is often refractory to treatment; no treatment is consistently effective. Treatment is individualized and depends on other medical conditions, known medication allergies, and potential for drug-drug interactions. Drugs shown to be effective in relieving pain in some individuals include: aspirin, misoprostol, serotonin-norepinephrine reuptake inhibitors and selective serotonin reuptake inhibitors, gabapentin, sodium channel blockers, carbamazepine, tricyclic antidepressants, calcium antagonists, magnesium, sodium nitroprusside infusion, and cyclosporine. Other treatments include: sympathetic block, surgical sympathectomy, and epidural infusion of opiates. Cooling of the extremities typically reduces pain in a symptomatic person.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Avoidance of triggers (warmth, prolonged standing) may reduce the number or severity of episodes.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Secondary complications from prolonged immersion in ice baths include: skin maceration, infection, and gangrene; cooling with a fan is generally safer than immersion in water.</p>
          <p><italic toggle="yes">Surveillence:</italic> There are no published guidelines for surveillance; however, it is important to monitor for side effects of treatment.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Heat, standing, alcohol, and spicy foods may trigger symptoms.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">SCN9A</italic>-related IEM is inherited in an autosomal dominant manner. If a parent of the proband is affected, the risk to the sibs is 50%. Each child of an individual with an <italic toggle="yes">SCN9A</italic>-related IEM pathogenic variant has a 50% chance of inheriting the variant.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="etha.Diagnosis">
        <title>Diagnosis</title>
        <sec id="etha.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnosis of <italic toggle="yes">SCN9A</italic>-related inherited erythromelalgia (<italic toggle="yes">SCN9A</italic>-related IEM), also known as primary erythromelalgia or erythermalgia, is made on clinical grounds.</p>
          <p><italic toggle="yes">SCN9A</italic>-related IEM is characterized by recurrent episodes of bilateral intense, burning pain; redness; warmth; and (occasionally) swelling affecting the distal extremities. The feet are more commonly affected than the hands, but, in severely affected individuals, symptoms may involve the legs, arms, face, or ears.</p>
          <p>Note: If symptoms are intermittent, photographs of the affected extremities during a flare can help with diagnosis (see <xref ref-type="fig" rid="etha.F1">Figure 1</xref>).</p>
          <p><italic toggle="yes">SCN9A</italic>-related IEM is not associated with an organic disease.</p>
          <p>Note: In the initial evaluation of painful, erythematous extremities, other treatable conditions resulting in secondary EM must be excluded (see <xref ref-type="sec" rid="etha.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
          <p>The disorder is confirmed by detection of an <italic toggle="yes">SCN9A</italic> pathogenic variant in a clinical laboratory.</p>
        </sec>
        <sec id="etha.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold> Pathogenic variants in <italic toggle="yes">SCN9A</italic> encoding the sodium channel protein Na<sub>v</sub>1.7 subunit are known to cause IEM [<xref ref-type="bibr" rid="etha.REF.yang.2004.171">Yang et al 2004</xref>, <xref ref-type="bibr" rid="etha.REF.dibhajj.2005.1847">Dib-Hajj et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.drenth.2005.1333">Drenth et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.michiels.2005.1587">Michiels et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.han.2006.553">Han et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.harty.2006.12566">Harty et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.lee.2007.210">Lee et al 2007</xref>, <xref ref-type="bibr" rid="etha.REF.takahashi.2007.157">Takahashi et al 2007</xref>].</p>
          <p>
            <bold>Evidence for locus heterogeneity</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Linkage to chromosome 2q was excluded in a three-generation family [<xref ref-type="bibr" rid="etha.REF.burns.2005.174">Burns et al 2005</xref>], suggesting the possible existence of additional genes in which mutation is causative.</p>
            </list-item>
            <list-item>
              <p>Exclusion of pathogenic variants in <italic toggle="yes">SCN9A, SCN10A,</italic> and <italic toggle="yes">SCN11A</italic> in familial cases also supports genetic heterogeneity [<xref ref-type="bibr" rid="etha.REF.drenth.2008.320">Drenth et al 2008</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Clinical testing</bold>
          </p>
          <table-wrap id="etha.T.summary_of_molecular_genetic_test" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">SCN9A</italic>-Related Inherited Erythromelalgia</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="3" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="3" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_2">Test Method</th>
                  <th id="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_3" rowspan="3" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_3">Allelic Variants Detected&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Variant Detection Frequency&#x000a0;<sup>3,&#x000a0;4</sup></th>
                </tr>
                <tr>
                  <th headers="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_4" id="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_2_1" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Family History&#x000a0;<sup>5</sup></th>
                </tr>
                <tr>
                  <th headers="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_4 hd_h_etha.T.summary_of_molecular_genetic_test_1_1_2_1" id="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_3_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Positive</th>
                  <th headers="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_4 hd_h_etha.T.summary_of_molecular_genetic_test_1_1_2_1" id="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_3_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Negative</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">SCN9A</italic>
                  </td>
                  <td headers="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  <td headers="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_4 hd_h_etha.T.summary_of_molecular_genetic_test_1_1_2_1 hd_h_etha.T.summary_of_molecular_genetic_test_1_1_3_1" valign="middle" align="left" rowspan="1" colspan="1">50%-100%</td>
                  <td headers="hd_h_etha.T.summary_of_molecular_genetic_test_1_1_1_4 hd_h_etha.T.summary_of_molecular_genetic_test_1_1_2_1 hd_h_etha.T.summary_of_molecular_genetic_test_1_1_3_2" valign="middle" align="left" rowspan="1" colspan="1">~30%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="etha.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="etha" object-id="etha.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="etha.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="etha.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="etha.TF.1.3">
                <label>3. </label>
                <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
              </fn>
              <fn id="etha.TF.1.4">
                <label>4. </label>
                <p>Because so few individuals have been tested to date, detection rates need to be considered preliminary.</p>
              </fn>
              <fn id="etha.TF.1.5">
                <label>5. </label>
                <p>Variant detection frequency differs depending on whether the family history is positive (i.e., other family members are affected) or negative (no other family members are affected) [<xref ref-type="bibr" rid="etha.REF.yang.2004.171">Yang et al 2004</xref>, <xref ref-type="bibr" rid="etha.REF.dibhajj.2005.1847">Dib-Hajj et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.drenth.2005.1333">Drenth et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.michiels.2005.1587">Michiels et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.han.2006.553">Han et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.harty.2006.12566">Harty et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.lee.2007.210">Lee et al 2007</xref>, <xref ref-type="bibr" rid="etha.REF.takahashi.2007.157">Takahashi et al 2007</xref>, <xref ref-type="bibr" rid="etha.REF.drenth.2008.320">Drenth et al 2008</xref>].</p>
              </fn>
              <fn id="etha.TF.1.6">
                <label>6. </label>
                <p>Examples of pathogenic variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="etha.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband,</bold> sequence analysis of <italic toggle="yes">SCN9A</italic> is performed.</p>
          <p><italic toggle="yes">SCN9A</italic> may also be represented on multi-gene panels used to evaluate individuals with seizure disorders.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant in the family.</p>
        </sec>
      </sec>
      <sec id="etha.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="etha.Clinical_Description">
          <title>Clinical Description</title>
          <p><italic toggle="yes">SCN9A</italic>-related inherited erythromelalgia (<italic toggle="yes">SCN9A</italic>-related IEM) is characterized by recurrent attacks of intense pain, redness, warmth, and swelling involving the feet and, less frequently, the hands [<xref ref-type="bibr" rid="etha.REF.dibhajj.2007.555">Dib-Hajj et al 2007</xref>, <xref ref-type="bibr" rid="etha.REF.drenth.2007.3603">Drenth &#x00026; Waxman 2007</xref>]. Warmth is an essential part of the syndrome. During the attacks, the extremities appear red or purple and may be swollen. Commonly, the attacks occur in the evening or at night and so may not be observed by a physician. The individual may seek medical advice for painful extremities but neglect to mention the characteristic warmth or redness (especially if limited to the soles of the feet). The symptoms are usually bilateral and symmetric. Within a family, the manifestations of the disorder may vary considerably.</p>
          <p>Onset of <italic toggle="yes">SCN9A</italic>-related IEM is usually in childhood or adolescence; however, it has been recognized in infants in families who are familiar with the disorder. Although rare, onset of <italic toggle="yes">SCN9A</italic>-related IEM has been reported in individuals or families after age 20 years [<xref ref-type="bibr" rid="etha.REF.choi.2010.1823">Choi et al 2010</xref>].</p>
          <p>Initially, the symptoms involve the soles of the feet and the hands; with age, the lower legs and the arms may become involved. In individuals with advanced disease, symptoms may occur many times a day and last hours, especially at night, or become constant and unremitting.</p>
          <p>At the onset, the episodes are triggered by exposure to warmth. A pathognomonic feature is triggering of episodes by warm or hot ambient temperature and relief with cooling of the extremities.</p>
          <p>Less consistent precipitating factors include: exercise, tight shoes, wearing socks, alcohol, spicy foods, and other vasodilating agents.</p>
          <p>Some individuals have allodynia (pain evoked by a normally innocuous stimulus) and hyperalgesia (increased sensitivity to a painful stimulus).</p>
          <p>The episodes may be disabling, interfere with sleep, and severely limit normal activities such as walking, participation in sports, wearing socks and shoes, and attending school or going to work. Individuals tend to limit their activities in warm weather and to stay in air-conditioned environments. Some individuals move from hot, humid climates to cooler climates.</p>
          <p>Affected individuals prefer to wear open-toed shoes and to sleep with their feet uncovered. Swimming can be helpful because it keeps the limbs cool during exercise.</p>
          <p><bold>Neurologic examination</bold> is typically normal, although reduced ankle reflexes and decreased distal sensation can be seen.</p>
          <p><bold>Electrophysiologic studies.</bold> Nerve conduction velocity studies and electromyography were reported to be abnormal in 14 of 24 individuals with "idiopathic" erythermalgia [<xref ref-type="bibr" rid="etha.REF.davis.2003.1337">Davis et al 2003</xref>]. It is unknown if the prevalence of electrophysiologic abnormalities is similar in individuals with <italic toggle="yes">SCN9A</italic>-related IEM.</p>
          <p><bold>Histopathologic examination</bold> of skin biopsy shows nonspecific thickening of blood vessel basement membrane, perivascular edema and mononuclear infiltrate, and reduced density of the autonomic nerve plexuses.</p>
          <p><bold>Pathophysiology.</bold> Underlying mechanisms that have been proposed:</p>
          <list list-type="bullet">
            <list-item>
              <p>Alterations in microvascular blood flow or capillary density [<xref ref-type="bibr" rid="etha.REF.mork.2000a.643">Mork et al 2000a</xref>, <xref ref-type="bibr" rid="etha.REF.mork.2002.949">Mork et al 2002</xref>, <xref ref-type="bibr" rid="etha.REF.davis.2003.1337">Davis et al 2003</xref>]</p>
            </list-item>
            <list-item>
              <p>Interplay between neural and vasoactive agents [<xref ref-type="bibr" rid="etha.REF.littleford.1999.507">Littleford et al 1999</xref>]</p>
            </list-item>
            <list-item>
              <p>Small-fiber neuropathy [<xref ref-type="bibr" rid="etha.REF.davis.2003.1337">Davis et al 2003</xref>, <xref ref-type="bibr" rid="etha.REF.orstavik.2003.567">Orstavik et al 2003</xref>, <xref ref-type="bibr" rid="etha.REF.orstavik.2004.531">Orstavik et al 2004</xref>]</p>
            </list-item>
          </list>
          <p>Although vasculopathy and neuropathy may coexist in individuals with primary or secondary EM, it is not possible to distinguish cause from secondary effects.</p>
        </sec>
        <sec id="etha.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Disease severity varies within families; whether the cause of the variation is genetic or environmental is unknown.</p>
          <p>Age of onset of symptoms has been correlated with the degree of the shift in activation of the voltage-gated sodium channel produced by pathogenic variants in <italic toggle="yes">SCN9A</italic>, with older onset associated with smaller shifts in channel activation [<xref ref-type="bibr" rid="etha.REF.cheng.2008.1">Cheng et al 2008</xref>, <xref ref-type="bibr" rid="etha.REF.han.2009.1711">Han et al 2009</xref>].</p>
          <p>Paroxysmal extreme pain disorder may be more responsive to carbamazepine than <italic toggle="yes">SCN9A</italic>-related IEM, which has a less consistent response. A correlation may exist between individual pathogenic variants and response to drugs that block the sodium channel [<xref ref-type="bibr" rid="etha.REF.drenth.2007.3603">Drenth &#x00026; Waxman 2007</xref>, <xref ref-type="bibr" rid="etha.REF.dibhajj.2013.49">Dib-Hajj et al 2013</xref>].</p>
        </sec>
        <sec id="etha.Penetrance">
          <title>Penetrance</title>
          <p>The penetrance in families with <italic toggle="yes">SCN9A</italic>-related IEM reported to date is 100%; however, molecular genetic data are available for fewer than 30 families.</p>
        </sec>
        <sec id="etha.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation has not been reported.</p>
        </sec>
        <sec id="etha.Nomenclature">
          <title>Nomenclature</title>
          <p>The term "erythromelalgia" was coined by the American neurologist S Weir Mitchell, MD, and is derived from the Greek words: erythro (red), melos (extremity), and algos (pain) [<xref ref-type="bibr" rid="etha.REF.mitchell.1878.2">Mitchell 1878</xref>].</p>
          <p>Some authors have proposed the term "erythermalgia" for the idiopathic genetic form of EM, and "erythromelalgia" for disease associated with an underlying medical condition or drug [<xref ref-type="bibr" rid="etha.REF.drenth.1994.393">Drenth &#x00026; Michiels 1994</xref>].</p>
          <p>Other authors prefer "erythromelalgia" for both idiopathic (primary) EM and acquired forms of the disease (secondary EM).</p>
        </sec>
        <sec id="etha.Prevalence">
          <title>Prevalence</title>
          <p>No accurate data on the worldwide prevalence of <italic toggle="yes">SCN9A</italic>-related IEM are available.</p>
          <p>One study estimated the prevalence of all forms of EM to be 2:100,000 in Norway [<xref ref-type="bibr" rid="etha.REF.kvernebo.1998.1">Kvernebo 1998</xref>].</p>
          <p>Thus far, families with a clinical diagnosis of erythromelalgia (some with an <italic toggle="yes">SCN9A</italic> pathogenic variant) have been identified in Canada, China, Japan, Taiwan, France, Belgium, the Netherlands, the United Kingdom, and the United States [<xref ref-type="bibr" rid="etha.REF.sano.2003.816">Sano et al 2003</xref>, <xref ref-type="bibr" rid="etha.REF.yang.2004.171">Yang et al 2004</xref>, <xref ref-type="bibr" rid="etha.REF.dibhajj.2005.1847">Dib-Hajj et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.drenth.2005.1333">Drenth et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.michiels.2005.1587">Michiels et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.han.2006.553">Han et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.lee.2007.210">Lee et al 2007</xref>, <xref ref-type="bibr" rid="etha.REF.ahn.2010.944">Ahn et al 2010</xref>].</p>
          <p>It is likely that erythromelalgia is underdiagnosed or often misdiagnosed.</p>
        </sec>
      </sec>
      <sec id="etha.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold>Extreme pain disorder.</bold> Pathogenic variants in <italic toggle="yes">SCN9A</italic> have been reported in paroxysmal extreme pain disorder, previously termed familial rectal pain (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/167400">167400</ext-link>) [<xref ref-type="bibr" rid="etha.REF.fertleman.2004">Fertleman et al 2004</xref>, <xref ref-type="bibr" rid="etha.REF.fertleman.2006.1294">Fertleman &#x00026; Ferrie 2006</xref>, <xref ref-type="bibr" rid="etha.REF.fertleman.2006.767">Fertleman et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.fertleman.2007.586">Fertleman et al 2007</xref>]. This autosomal dominant disorder is characterized by episodes of rectal, ocular, or submandibular pain accompanied by erythema.</p>
        <p><bold>Insensitivity to pain.</bold> Pathogenic variants in <italic toggle="yes">SCN9A</italic> resulting in loss of function of sodium channel Na<sub>v</sub>1.7 subunit alpha cause channelopathy-associated insensitivity to pain (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/243000">243000</ext-link>) [<xref ref-type="bibr" rid="etha.REF.cox.2006.894">Cox et al 2006</xref>]. Three nonsense homozygous pathogenic variants in <italic toggle="yes">SCN9A</italic> were identified in six affected individuals from three consanguineous families. All affected children (age range: 4-14 years) had insensitivity to pain and were otherwise normal and healthy. Loss-of-function variants have been identified in patients from various ethnic backgrounds [<xref ref-type="bibr" rid="etha.REF.ahmad.2007.2114">Ahmad et al 2007</xref>, <xref ref-type="bibr" rid="etha.REF.goldberg.2007.311">Goldberg et al 2007</xref>].</p>
        <p><bold>Small fiber neuropathy.</bold> Pathogenic missense variants in <italic toggle="yes">SCN9A</italic> have been reported in eight of 28 adult (age &#x02265;18 years) individuals with small fiber neuropathy in whom known causes for small fiber neuropathy (e.g., diabetes mellitus, impaired glucose tolerance, hyperlipidemia) were excluded, and who met strict diagnostic criteria for idiopathic small fiber neuropathy [<xref ref-type="bibr" rid="etha.REF.faber.2012.26">Faber et al 2012</xref>].</p>
        <p><bold>Febrile seizures and epilepsy.</bold> Pathogenic variants in <italic toggle="yes">SCN9A</italic> have been reported in a large Utah family with generalized epilepsy febrile seizures plus (GEFS+) as well as in unrelated individuals with simple febrile seizures [<xref ref-type="bibr" rid="etha.REF.singh.2009.e1000649">Singh et al 2009</xref>]. Clinical features include onset of childhood febrile seizures, persistence of afebrile seizures beyond childhood, and a broad range of seizure manifestations, including intractable epilepsy.</p>
      </sec>
      <sec id="etha.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of <italic toggle="yes">SCN9A</italic>-related inherited erythromelalgia (<italic toggle="yes">SCN9A</italic>-related IEM) includes <xref ref-type="sec" rid="etha.Secondary_EM">secondary EM</xref> resulting from an underlying organic disease, medication, or toxin; <xref ref-type="sec" rid="etha.Neuropathies">neuropathies</xref>; <xref ref-type="sec" rid="etha.Other_Conditions">other conditions</xref> with some overlapping features; and <xref ref-type="sec" rid="etha.IEM_Not_Related_to_Mutation_of_SCN9">inherited erythromelalgia in which no <italic toggle="yes">SCN9A</italic> pathogenic variant</xref> is identified.</p>
        <sec id="etha.Secondary_EM">
          <title>Secondary EM</title>
          <p>Secondary erythromelalgia occurs in a variety of disorders and begins at any age. Medications and toxins are potentially reversible causes of secondary erythromelalgia:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Essential thrombocythemia,</bold> a myeloproliferative disorder, is the most significant cause of secondary erythromelalgia, occurring in up to 25% of individuals with this condition [<xref ref-type="bibr" rid="etha.REF.drenth.1994.393">Drenth &#x00026; Michiels 1994</xref>, <xref ref-type="bibr" rid="etha.REF.mccarthy.2002.1245">McCarthy et al 2002</xref>]. Erythromelalgia is frequently the presenting complaint and may precede a diagnosis of myeloproliferative disease by several years. A significant clinical characteristic of erythromelalgia secondary to thrombocythemia is marked pain relief lasting up to several days following ingestion of a single dose of aspirin. Neither <italic toggle="yes">SCN9A</italic>-related IEM nor other forms of secondary EM demonstrate the same dramatic response to aspirin treatment.</p>
            </list-item>
            <list-item>
              <p><bold>Polycythemia vera</bold> or <bold>thrombotic thrombocytopenic purpura</bold></p>
            </list-item>
            <list-item>
              <p><bold>Rheumatologic disorders</bold> such as gout and <bold>autoimmune disorders</bold> including systemic lupus erythematosus (SLE), rheumatoid arthritis, or vasculitis</p>
            </list-item>
            <list-item>
              <p><bold>Paraneoplastic syndrome,</bold> a rare cause of secondary erythromelalgia [<xref ref-type="bibr" rid="etha.REF.mork.1999.394">Mork et al 1999</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>Medications</bold> such as verapamil, nifedipine, bromocriptine, and ticlopidine [<xref ref-type="bibr" rid="etha.REF.yosipovitch.1999.473">Yosipovitch et al 1999</xref>]</p>
            </list-item>
            <list-item>
              <p>
                <bold>Environmental toxins</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Inorganic mercury poisoning, which produces acrodynia (erythema and edema of the hands and feet)</p>
                </list-item>
                <list-item>
                  <p>Mushroom poisoning [<xref ref-type="bibr" rid="etha.REF.diaz.2005.427">Diaz 2005</xref>]</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="etha.Neuropathies">
          <title>Neuropathies</title>
          <p>Painful neuropathies associated with diabetes mellitus, alcoholism, HIV infection, idiopathic small fiber neuropathy, and Lyme disease may cause burning pain similar to erythromelalgia but are much less likely to be associated with redness, warmth, heat intolerance, and relief with cooling [<xref ref-type="bibr" rid="etha.REF.mork.2000b.498">Mork et al 2000b</xref>].</p>
        </sec>
        <sec id="etha.Other_Conditions">
          <title>Other Conditions</title>
          <p><bold>Reflex sympathetic dystrophy (RSD),</bold> a complex regional pain syndrome, may be indistinguishable from <italic toggle="yes">SCN9A</italic>-related IEM in its early stages; however, RSD is much more likely to be unilateral. RSD usually follows an injury in the affected limb, such as a wrist fracture, typically evolves to include signs such as reduced circulation, and may also be associated with changes in the nails, joints, or bone density [<xref ref-type="bibr" rid="etha.REF.schott.2001.291">Schott 2001</xref>].</p>
          <p><bold>Peripheral vascular disease</bold> may be associated with pain of the distal extremities triggered by exercise (claudication) and, with chronic disease, cause change in skin color. Peripheral vascular disease is associated with smoking and cardiovascular or cerebrovascular disease.</p>
          <p><bold>Raynaud's phenomenon,</bold> in contrast to <italic toggle="yes">SCN9A</italic>-related IEM, is typically exacerbated by exposure to cold, with vasospasm, pain, and skin color changes.</p>
          <p><related-object link-type="booklink" source-id="gene" document-id="fabry" document-type="chapter"><bold>Fabry disease</bold></related-object> causes burning pain of the distal extremities in childhood but is differentiated by an X-linked pattern of inheritance and other clinical features including angiokeratomas, characteristic corneal and lenticular opacities, and increased occurrence of renal and cerebrovascular disease.</p>
        </sec>
        <sec id="etha.IEM_Not_Related_to_Mutation_of_SCN9">
          <title>IEM Not Related to Mutation of <italic toggle="yes">SCN9A</italic></title>
          <p>A three-generation family with EM, in which pathogenic variants in <italic toggle="yes">SCN9A</italic> were excluded by variant screening and linkage to the <italic toggle="yes">SCN9A</italic> locus was excluded by linkage analysis and haplotype analysis, has been reported [<xref ref-type="bibr" rid="etha.REF.burns.2005.174">Burns et al 2005</xref>]. A distinctive clinical feature was an age of onset ranging from 21 years to 76 years. The molecular basis of this condition is unknown.</p>
          <p>Additional families with IEM have been tested for pathogenic variants in <italic toggle="yes">SCN9A, SCN10A,</italic> and <italic toggle="yes">SCN11A</italic> with normal results, lending additional support for genetic heterogeneity in this condition [<xref ref-type="bibr" rid="etha.REF.drenth.2008.320">Drenth et al 2008</xref>].</p>
        </sec>
      </sec>
      <sec id="etha.Management">
        <title>Management</title>
        <sec id="etha.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">SCN9A</italic>-related inherited erythromelalgia (<italic toggle="yes">SCN9A</italic>-related IEM), the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Assessment of the pain management strategies used (see <xref ref-type="sec" rid="etha.Treatment_of_Manifestations">Treatment of Manifestations</xref>)</p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="etha.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The pain of <italic toggle="yes">SCN9A</italic>-related IEM or secondary erythromelalgia is often refractory to treatment.</p>
          <p>Reports on treatments in a series involve heterogeneous populations. In a report of 169 individuals with erythromelalgia of mixed etiologies, 84 medications or treatments were used [<xref ref-type="bibr" rid="etha.REF.davis.2000.330">Davis et al 2000</xref>]. Response is highly variable, and no treatment is consistently effective. No controlled treatment trial has compared the effectiveness of various classes of medications.</p>
          <p><bold>Cooling the extremities</bold> reduces pain in a symptomatic person.</p>
          <p><bold>Medications</bold>. The effectiveness of medications and the order in which they should be tried is highly controversial, according to a consensus of expert opinion. Treatment should be determined by the individual&#x02019;s treating physician, based on factors including other medical conditions, known medication allergies, and potential for drug-drug interactions.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Aspirin</bold> should be tried because of the known, dramatic response of thrombocythemia-associated EM to low-dose aspirin. A positive response warrants evaluation for and monitoring for myeloproliferative disease because the symptoms of thrombocythemia-associated EM may precede a diagnosis by several years. If pain is not relieved, aspirin should be discontinued.</p>
            </list-item>
            <list-item>
              <p><bold>Misoprostol,</bold> an oral prostaglandin E1 analog, was tested in a double-blind, placebo-controlled, one-way crossover clinical trial in 21 adults with erythromelalgia and 11 healthy controls. Improvements in pain and cooling scores were significant (p&#x0003c;0.01) [<xref ref-type="bibr" rid="etha.REF.mork.2004.587">Mork et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Seratonin-norepinephrine reuptake inhibitors (SNRIs) /selective serotonin reuptake inhibitors (SSRIs).</bold> Venlafaxine, an SNRI, has induced remissions in approximately a dozen individuals even after other classes of medications have been unsuccessful [<xref ref-type="bibr" rid="etha.REF.dicaudo.2004.621">DiCaudo &#x00026; Kelley 2004</xref>]. SSRIs (fluoxetine, sertraline) have been reported to be helpful in some additional affected individuals.</p>
            </list-item>
            <list-item>
              <p><bold>Gabapentin</bold> has been one of the more effective medical treatments in both primary and secondary EM. Of 16 individuals taking gabapentin in a survey of Erythromelalgia Association members, all 16 reported benefit, although the degree was not quantified. Experts have reported typically mild to moderate pain relief. Remissions (i.e., remaining pain-free for 4-6 months) on gabapentin have been reported in an adult and a child [<xref ref-type="bibr" rid="etha.REF.cohen.2000.841">Cohen 2000</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Sodium channel blockers</bold> including lidocaine infusion, lidocaine patch, or oral mexilitine have been used successfully in inherited erythromelalgia and secondary erythromelalgia [<xref ref-type="bibr" rid="etha.REF.kuhnert.1999.1447">Kuhnert et al 1999</xref>, <xref ref-type="bibr" rid="etha.REF.davis.2005.1320">Davis &#x00026; Sandroni 2005</xref>, <xref ref-type="bibr" rid="etha.REF.nathan.2005.e504">Nathan et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.choi.2009.383">Choi et al 2009</xref>]. Because of the absence of systemic side effects, partial relief in 55% of the individuals studied, and greater than 80% pain relief in 12% of individuals, <xref ref-type="bibr" rid="etha.REF.davis.2005.1320">Davis &#x00026; Sandroni [2005]</xref> have suggested a lidocaine patch as first-line treatment. It is not known whether sodium channel blockers are more effective in individuals with <italic toggle="yes">SCN9A</italic>-related IEM than in individuals with other forms of EM.</p>
            </list-item>
            <list-item>
              <p><bold>Carbamazepine</bold>. In a survey of 41 members of the Erythromelalgia Association, one of four persons using carbamazepine reported improvement [<xref ref-type="bibr" rid="etha.REF.cohen.2000.841">Cohen 2000</xref>]. A family with a known <italic toggle="yes">SCN9A</italic> pathogenic variant (p.Val400Met) reported significant improvement of symptoms while using carbamazepine [<xref ref-type="bibr" rid="etha.REF.fischer.2009.733">Fischer et al 2009</xref>].The combination of carbamazepine and gabapentin has been reported to produce relief in one individual with <italic toggle="yes">SCN9A</italic>-related IEM [<xref ref-type="bibr" rid="etha.REF.natkunarajah.2009.e640">Natkunarajah et al 2009</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Oxcarbazepine</bold> use in treating EM has not been reported.</p>
            </list-item>
            <list-item>
              <p><bold>Tricyclic antidepressants</bold> used alone or in combination with other classes of medications have reduced pain. Their use has diminished with the introduction of newer agents with a more favorable side-effect profile, but they should be considered in refractory individuals. Topical application of 1.0% amitriptyline hydrochloride and 0.5% ketamine hydrochloride in pluronic lecithin organogel has been reported effective in four of five patients with refractory EM [<xref ref-type="bibr" rid="etha.REF.sandroni.2006.283">Sandroni &#x00026; Davis 2006</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Calcium antagonists.</bold> Diltiazem is very effective in some individuals, inducing at least one remission. Paradoxically, diltiazem and other calcium channel antagonists have been reported to trigger secondary EM.</p>
            </list-item>
            <list-item>
              <p><bold>Magnesium.</bold> In 13 persons, high doses of oral magnesium induced remission in one person, improved symptoms in seven, did not change them in four, and exacerbated symptoms in one. Diarrhea was a limiting side effect [<xref ref-type="bibr" rid="etha.REF.cohen.2002.255">Cohen 2002</xref>]. Remission (freedom from pain) was also reported in an Italian child [<xref ref-type="bibr" rid="etha.REF.dellera.2004.125">Dell'era et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Sodium nitroprusside infusion</bold> has been successful in the acute hospital setting in individuals with severe attacks [<xref ref-type="bibr" rid="etha.REF.chan.2002.229">Chan et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Cyclosporine</bold> was successful in one person with erythromelalgia. The postulated mechanism was inhibition of nitric oxide synthase in vascular smooth muscle and endothelial cells [<xref ref-type="bibr" rid="etha.REF.sano.2003.816">Sano et al 2003</xref>]. Conversely, cyclosporine caused EM in another individual treated for psoriasis vulgaris [<xref ref-type="bibr" rid="etha.REF.thami.2003.910">Thami &#x00026; Bhalla 2003</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Sympathetic block, surgical sympathectomy, and epidural infusion</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Sympathetic block has had mixed results in individuals with severe symptoms. Some have improved, some have not improved, and others have worsened [<xref ref-type="bibr" rid="etha.REF.cohen.2000.841">Cohen 2000</xref>]. Sympathetic block should be tried &#x02013; and the response to repeated blocks considered &#x02013; prior to surgical sympathectomy.</p>
            </list-item>
            <list-item>
              <p>In at least two individuals, sympathectomy reduced redness but not pain.</p>
            </list-item>
            <list-item>
              <p>Epidural infusions of opiates have been used in combination with bupivicaine and other oral and topical medications with good results in a few individuals.</p>
            </list-item>
          </list>
          <p>
            <bold>Other</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Reports of a single or a few individuals have noted remission or significant improvement with cyproheptadine, propranolol, or thalamic stimulation [<xref ref-type="bibr" rid="etha.REF.delye.2005.e404">Delye et al 2005</xref>].</p>
            </list-item>
            <list-item>
              <p>Additional combinations of medical, surgical, and alternative treatments tried with varying success in individuals with either primary EM or secondary EM are summarized by <xref ref-type="bibr" rid="etha.REF.davis.2000.330">Davis et al [2000]</xref> (see Table 2) and <xref ref-type="bibr" rid="etha.REF.cohen.2000.841">Cohen [2000]</xref> (see Table 3).</p>
            </list-item>
          </list>
        </sec>
        <sec id="etha.Prevention_of_Primary_Manifestation">
          <title>Prevention of Primary Manifestations</title>
          <p>Avoidance of triggers (warmth, prolonged standing) may reduce the number or severity of episodes.</p>
        </sec>
        <sec id="etha.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Secondary complications from prolonged immersion in ice baths include: skin maceration, infection, and gangrene. Amputation has occasionally been necessary to treat these complications.</p>
          <p>Cooling with a fan is generally safer than immersion in water.</p>
        </sec>
        <sec id="etha.Surveillance">
          <title>Surveillance</title>
          <p>There are no published guidelines for surveillance. Most affected individuals are treated in dermatology clinics, neurology clinics, or pain clinics, or by anesthesiologists specializing in the management of chronic pain. It is important to monitor for side effects of treatment.</p>
        </sec>
        <sec id="etha.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Symptoms are triggered by warmth and standing and, in some individuals, by alcohol and spicy foods including chili peppers or garlic.</p>
          <p>In some individuals, exercise can trigger symptoms. However, for many individuals, the benefits of mild exercise outweigh the disadvantages. Swimming is a preferred exercise because the extremities remain cool.</p>
        </sec>
        <sec id="etha.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="etha.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="etha.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Potential teratogenic effects of medications given for treatment of erythromelalgia should be discussed with affected women of childbearing age. The ideal time to discuss this is prior to conception.</p>
        </sec>
        <sec id="etha.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Small molecule inhibitors of the <italic toggle="yes">SCN9A</italic> encoded sodium channel Na<sub>v</sub>1.7 have been developed. In one exploratory, randomized, double-blind crossover trial of four subjects with EM in whom the presence of <italic toggle="yes">SCN9A</italic> pathogenic variants had been confirmed, the compound was reported to be more effective than placebo in reducing the amount of pain for two hours following a pain induction stimulus [<xref ref-type="bibr" rid="etha.REF.goldberg.2012.80">Goldberg et al 2012</xref>]. Given the small number of treated individuals and short duration of the study, strong conclusions cannot be drawn from these results.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="etha.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="etha.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">SCN9A</italic>-related inherited erythromelalgia (<italic toggle="yes">SCN9A</italic>-related IEM) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="etha.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Many individuals diagnosed with <italic toggle="yes">SCN9A</italic>-related IEM have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with <italic toggle="yes">SCN9A</italic>-related IEM may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> mutation is unknown because the evaluation of family members for milder symptoms has been incomplete and molecular genetic data are insufficient.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include: a detailed clinical and family history and molecular genetic testing of both parents if the pathogenic variant has been identified in the proband. In a simplex case (individual with no known family history of <italic toggle="yes">SCN9A</italic>-related IEM), the data on heritability are incomplete.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. The risk to the sibs of a proband appears to be low but greater than that of the general population because of the possibility of germline mosaicism. Two affected sibs with an unaffected mosaic father have been reported [<xref ref-type="bibr" rid="etha.REF.han.2006.553">Han et al 2006</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with an IEM-causing variant in <italic toggle="yes">SCN9A</italic> has a 50% chance of inheriting the variant.</p>
          <p>
            <bold>Other family members of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent is affected or has a pathogenic variant, his or her family members are at risk.</p>
            </list-item>
          </list>
        </sec>
        <sec id="etha.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has clinical evidence of the disorder or the pathogenic variant, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, possible non-medical explanations, including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="etha.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing for this disease/gene or custom prenatal testing.</p>
          <p>Requests for prenatal testing for conditions which (like <italic toggle="yes">SCN9A</italic>-related IEM) do not affect intellect and have some treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variant has been identified.</p>
        </sec>
      </sec>
      <sec id="etha.Resources">
        <title>Resources</title>
      </sec>
      <sec id="etha.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="etha.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>A number of reviews [<xref ref-type="bibr" rid="etha.REF.waxman.2005a.785">Waxman &#x00026; Dib-Hajj 2005a</xref>, <xref ref-type="bibr" rid="etha.REF.waxman.2005b.555">Waxman &#x00026; Dib-Hajj 2005b</xref>, <xref ref-type="bibr" rid="etha.REF.dibhajj.2007.555">Dib-Hajj et al 2007</xref>, <xref ref-type="bibr" rid="etha.REF.drenth.2007.3603">Drenth &#x00026; Waxman 2007</xref>] describe the molecular genetic pathogenesis of <italic toggle="yes">SCN9A</italic>-related inherited erythromelalgia (<italic toggle="yes">SCN9A</italic>-related IEM), which is associated with mutation of the gene that encodes the sodium channel protein type 9 alpha subunit (also known as the voltage-gated sodium channel subunit alpha Na<sub>v</sub>1.7) [<xref ref-type="bibr" rid="etha.REF.drenth.2001.1277">Drenth et al 2001</xref>, <xref ref-type="bibr" rid="etha.REF.yang.2004.171">Yang et al 2004</xref>, <xref ref-type="bibr" rid="etha.REF.dibhajj.2005.1847">Dib-Hajj et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.drenth.2005.1333">Drenth et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.michiels.2005.1587">Michiels et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.han.2006.553">Han et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.harty.2006.12566">Harty et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.lee.2007.210">Lee et al 2007</xref>, <xref ref-type="bibr" rid="etha.REF.takahashi.2007.157">Takahashi et al 2007</xref>]. The Na<sub>v</sub>1.7 sodium channel is preferentially expressed within dorsal root ganglia and sympathetic ganglion neurons [<xref ref-type="bibr" rid="etha.REF.djouhri.2003.565">Djouhri et al 2003</xref>]. These pathogenic variants alter the biophysical properties of the channel by shifting activation in a hyperpolarizing direction (thus lowering the threshold for channel opening) by slowing deactivation (thus keeping the channel open longer) and by increasing the response of the channel to small, slow depolarizations close to the resting potential [<xref ref-type="bibr" rid="etha.REF.cummins.2004.8232">Cummins et al 2004</xref>, <xref ref-type="bibr" rid="etha.REF.dibhajj.2005.1847">Dib-Hajj et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.choi.2006.1563">Choi et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.han.2006.553">Han et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.harty.2006.12566">Harty et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.lampert.2006.36029">Lampert et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.sheets.2007.1019">Sheets et al 2007</xref>, <xref ref-type="bibr" rid="etha.REF.cheng.2008.1">Cheng et al 2008</xref>]. The effects of these changes in channel properties have been studied within dorsal root ganglia neurons, in which they increase excitability and increase the frequency of firing [<xref ref-type="bibr" rid="etha.REF.dibhajj.2005.1847">Dib-Hajj et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.harty.2006.12566">Harty et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.rush.2006.8245">Rush et al 2006</xref>]. The Na<sub>v</sub>1.7 sodium channel is also expressed in neurons of the sympathetic ganglion. The expression of the IEM-causing variant p.Leu858His in superior cervical ganglion neurons (sympathetic neurons) causes these neurons to become less excitable [<xref ref-type="bibr" rid="etha.REF.rush.2006.8245">Rush et al 2006</xref>], which may contribute to the loss of tonic cutaneous vasoconstriction associated with skin flushing in individuals with IEM. See <xref ref-type="table" rid="etha.T.selected_scn9a_allelic_variants">Table 2</xref>.</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">SCN9A</italic> is composed of 26 exons spanning 167.3 Mb. Exon 5 (E5), which is 92 bp long, is present in embryonic/neonatal (E5N) and adult (E5A) isoforms [<xref ref-type="bibr" rid="etha.REF.raymond.2004.46234">Raymond et al 2004</xref>]. E5N is located upstream from E5A in <italic toggle="yes">SCN9A;</italic> the sequence encoded by these alternative exons differs by two amino acids only: Leu201 in E5N compared to Val201 in E5A (p.Leu201Val) and Asn206 in E5N compared to Asp206 in E5A (p.Asn206Asp). The control elements for this alternative splicing and the functional effect of these variants have yet to be determined.</p>
          <p>The utilization of an alternative 5' splice site for intron 12 lengthens exon 11 by 33 bp, leading to an extension of loop 1 (L1), which joins domains 1 and 2 by 11 amino acids for an Na<sub>v</sub>1.7 isoform of 1988 amino acids [<xref ref-type="bibr" rid="etha.REF.raymond.2004.46234">Raymond et al 2004</xref>]. The functional effect of the extension of L1 of Na<sub>v</sub>1.7 has yet to be determined.</p>
          <p>The orthologs of <italic toggle="yes">SCN9A</italic> have been identified in rat and rabbit. The exon-intron boundaries are highly conserved among rodent, rabbit, and human <italic toggle="yes">SCN9A</italic> in the regions that have been investigated. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="etha" object-id="etha.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic allelic variants.</bold> See <xref ref-type="table" rid="etha.T.selected_scn9a_allelic_variants">Table 2</xref>. Twenty missense variants in <italic toggle="yes">SCN9A</italic> have been identified and functionally validated in persons with <italic toggle="yes">SCN9A</italic>-related IEM and reported in public databases [reviewed in <xref ref-type="bibr" rid="etha.REF.dibhajj.2010.325">Dib-Hajj et al 2010</xref>, <xref ref-type="bibr" rid="etha.REF.estacion.2013.99">Estacion et al 2013</xref>]. The relative position of many pathogenic variants along the polypeptide is shown on the schematic of the channel in <xref ref-type="fig" rid="etha.F2">Figure 2</xref>. An additional seven variants of unknown functional effects on the channel properties or link to disease are reported in professional (limited-access) databases.</p>
          <p>Some <italic toggle="yes">SCN9A</italic> mutant alleles:</p>
          <list list-type="bullet">
            <list-item>
              <p>p.Ile136Val in the S1 of domain 1 [<xref ref-type="bibr" rid="etha.REF.lee.2007.210">Lee et al 2007</xref>, <xref ref-type="bibr" rid="etha.REF.cheng.2008.1">Cheng et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p>p.Phe216Ser in the S4 of domain I [<xref ref-type="bibr" rid="etha.REF.drenth.2005.1333">Drenth et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.choi.2006.1563">Choi et al 2006</xref>]</p>
            </list-item>
            <list-item>
              <p>p.Ser241Thr in the linker joining S4 and S5 of domain I [<xref ref-type="bibr" rid="etha.REF.michiels.2005.1587">Michiels et al 2005</xref>]</p>
            </list-item>
            <list-item>
              <p>p.Asn395Lys in the S6 of domain I [<xref ref-type="bibr" rid="etha.REF.drenth.2005.1333">Drenth et al 2005</xref>]</p>
            </list-item>
            <list-item>
              <p>p.Leu823Arg in the S4 of domain II [<xref ref-type="bibr" rid="etha.REF.takahashi.2007.157">Takahashi et al 2007</xref>]</p>
            </list-item>
            <list-item>
              <p>p.Ile848Thr, p.Leu858His, and p.Leu858Phe in the linker joining S4 and S5 of domain II [<xref ref-type="bibr" rid="etha.REF.yang.2004.171">Yang et al 2004</xref>, <xref ref-type="bibr" rid="etha.REF.drenth.2005.1333">Drenth et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.han.2006.553">Han et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.drenth.2008.320">Drenth et al 2008</xref>]Note: The contribution of the variant <xref ref-type="table" rid="etha.T.selected_scn9a_allelic_variants">p.Pro610Thr</xref> to the disease phenotype is not clear at this time; p.Pro610Thr has been reported in the same individual along with the p.Leu858Phe pathogenic variant in a multigenerational Canadian family [<xref ref-type="bibr" rid="etha.REF.drenth.2005.1333">Drenth et al 2005</xref>], suggesting that it is a benign allelic variant (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_002968.1">NP_002968.1</ext-link>). Protein change p.Leu858Phe was the only pathogenic variant reported in a Chinese individual; thus, this substitution alone is sufficient to alter the biophysical properties of mutant Na<sub>v</sub>1.7 /p.Leu858Phe channels [<xref ref-type="bibr" rid="etha.REF.han.2006.553">Han et al 2006</xref>], similar to the effect of the Na<sub>v</sub>1.7 /p.Leu858His mutant channel [<xref ref-type="bibr" rid="etha.REF.cummins.2004.8232">Cummins et al 2004</xref>]. Recently, analysis of the Canadian family has shown that p.Pro610Thr segregates independently of the p.Leu858Phe pathogenic variant and is present in one unaffected sibling in this family and in 10/210 ethnically matched control chromosomes [<xref ref-type="bibr" rid="etha.REF.samuels.2008.21">Samuels et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>p.Ala863Pro in the S5 of domain II [<xref ref-type="bibr" rid="etha.REF.harty.2006.12566">Harty et al 2006</xref>]</p>
            </list-item>
            <list-item>
              <p>p.Phe1449Val in the linker joining domains III and IV [<xref ref-type="bibr" rid="etha.REF.dibhajj.2005.1847">Dib-Hajj et al 2005</xref>]</p>
            </list-item>
          </list>
          <table-wrap id="etha.T.selected_scn9a_allelic_variants" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>Selected <italic toggle="yes">SCN9A</italic> Allelic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Class of Variant Allele</th>
                  <th id="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                  <th id="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Normal</bold>
                  </td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.601T&#x0003e;G</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Leu201Val</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_4" rowspan="14" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_002977.2">NM_002977.2</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_002968.1">NP_002968.1</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.616A&#x0003e;G</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asn206Asp</td>
                </tr>
                <tr>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.3448C&#x0003e;T</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg1150Trp</td>
                </tr>
                <tr>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_1" rowspan="11" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Pathogenic</bold>
                  </td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.406A&#x0003e;G</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ile136Val</td>
                </tr>
                <tr>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.647T&#x0003e;C</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Phe216Ser</td>
                </tr>
                <tr>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.721T&#x0003e;A</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ser241Thr</td>
                </tr>
                <tr>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1185C&#x0003e;A</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Asn395Lys</td>
                </tr>
                <tr>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1828C&#x0003e;A</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Pro610Thr&#x000a0;<sup>1</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2468T&#x0003e;G</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Leu823Arg</td>
                </tr>
                <tr>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2543T&#x0003e;C</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ile848Thr</td>
                </tr>
                <tr>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2573T&#x0003e;A</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Leu858His</td>
                </tr>
                <tr>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2572C&#x0003e;T</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Leu858Phe</td>
                </tr>
                <tr>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2587G&#x0003e;C</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ala863Pro</td>
                </tr>
                <tr>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.4345T&#x0003e;G</td>
                  <td headers="hd_h_etha.T.selected_scn9a_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Phe1449Val</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="etha.TF.2.1">
                <label>1. </label>
                <p>The contribution of the variant p.Pro610Thr to the disease phenotype is not clear (see <bold>Pathogenic allelic variants</bold>, Note).</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> The normal product of <italic toggle="yes">SCN9A</italic> is the sodium channel protein type 9 alpha subunit (voltage-gated sodium channel Na<sub>v</sub>1.7). Na<sub>v</sub>1.7 comprises 1977 amino acids organized into four domains, each with six transmembrane segments (S1-6), similar to members of the voltage-gated sodium and calcium ion channels [<xref ref-type="bibr" rid="etha.REF.catterall.2000.13">Catterall 2000</xref>]. The channel produces a fast inactivating sodium current that is sensitive to nanomolar concentrations of the neurotoxin tetrodotoxin (TTX-S). Na<sub>v</sub>1.7 is expressed predominantly in dorsal root ganglia neurons, particularly nociceptive neurons [<xref ref-type="bibr" rid="etha.REF.djouhri.2003.565">Djouhri et al 2003</xref>] and sympathetic ganglion neurons [<xref ref-type="bibr" rid="etha.REF.rush.2006.8245">Rush et al 2006</xref>]. Because of its slow closed-state inactivation, Na<sub>v</sub>1.7 produces depolarizing current in response to small depolarizing stimuli close to resting potential, thus amplifying small depolarizations such as generator potentials [<xref ref-type="bibr" rid="etha.REF.cummins.1998.9607">Cummins et al 1998</xref>].</p>
          <p><italic toggle="yes">SCN9A</italic> is expressed within dorsal root ganglion neurons and sympathetic ganglion neurons [<xref ref-type="bibr" rid="etha.REF.yang.2004.171">Yang et al 2004</xref>, <xref ref-type="bibr" rid="etha.REF.dibhajj.2005.1847">Dib-Hajj et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.drenth.2005.1333">Drenth et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.michiels.2005.1587">Michiels et al 2005</xref>, <xref ref-type="bibr" rid="etha.REF.han.2006.553">Han et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.rush.2006.8245">Rush et al 2006</xref>].</p>
          <p><bold>Abnormal gene product.</bold> Two pathogenic variants in <italic toggle="yes">SCN9A</italic> (p.Ile848Thr and p.Leu858His), identified in two Chinese families with <italic toggle="yes">SCN9A</italic>-related IEM, produce a hyperpolarizing shift in activation and slow deactivation, and enhance the channel's response to small depolarizing stimuli, changes that can confer hyperexcitability on cells in which the channel is expressed [<xref ref-type="bibr" rid="etha.REF.cummins.2004.8232">Cummins et al 2004</xref>].</p>
          <p>A third variant of <italic toggle="yes">SCN9A</italic> (p.Phe1449Val), from an American family with <italic toggle="yes">SCN9A</italic>-related IEM, produces a hyperpolarizing shift in activation and a depolarizing shift in steady-state inactivation and lowers thresholds of single action potentials and high-frequency firing in dorsal root ganglia neurons [<xref ref-type="bibr" rid="etha.REF.dibhajj.2005.1847">Dib-Hajj et al 2005</xref>].</p>
          <p>Several other pathogenic variants have been characterized by voltage-clamp recordings and show the common feature of hyperpolarizing shift in activation of the channel [<xref ref-type="bibr" rid="etha.REF.choi.2006.1563">Choi et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.han.2006.553">Han et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.harty.2006.12566">Harty et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.lampert.2006.36029">Lampert et al 2006</xref>, <xref ref-type="bibr" rid="etha.REF.sheets.2007.1019">Sheets et al 2007</xref>, <xref ref-type="bibr" rid="etha.REF.cheng.2008.1">Cheng et al 2008</xref>].</p>
        </sec>
      </sec>
      <sec id="etha.References">
        <title>References</title>
        <sec id="etha.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="etha.Literature_Cited.reflist0">
            <ref id="etha.REF.ahmad.2007.2114">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ahmad</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahllund</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eriksson</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellgren</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlsson</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijer</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meury</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mills</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moody</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morinville</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morten</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Donnell</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raynoschek</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salter</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krupp</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A stop codon mutation in SCN9A causes lack of pain sensation.</article-title>
                <source>Hum Mol Genet</source>
                <volume>16</volume>
                <fpage>2114</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">17597096</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.ahn.2010.944">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ahn</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyrrell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elmslie</surname>
                    <given-names>FV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drenth</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woods</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A new Na<sub>v</sub>1.7 sodium channel mutation I234T in a child with severe pain.</article-title>
                <source>Eur J Pain</source>
                <volume>14</volume>
                <fpage>944</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">20385509</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.burns.2005.174">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burns</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Te Morsche</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drenth</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genetic heterogeneity and exclusion of a modifying locus at 2q in a family with autosomal dominant primary erythermalgia.</article-title>
                <source>Br J Dermatol</source>
                <volume>153</volume>
                <fpage>174</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16029345</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.catterall.2000.13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Catterall</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels.</article-title>
                <source>Neuron</source>
                <volume>26</volume>
                <fpage>13</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">10798388</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.chan.2002.229">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madden</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golding</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atherton</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dillon</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Erythromelalgia: an endothelial disorder responsive to sodium nitroprusside.</article-title>
                <source>Arch Dis Child</source>
                <volume>87</volume>
                <fpage>229</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">12193436</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.cheng.2008.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyrrell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Mutation I136V alters electrophysiological properties of the Na<sub>v</sub>1.7 channel in a family with onset of erythromelalgia in the second decade.</article-title>
                <source>Mol Pain</source>
                <volume>4</volume>
                <fpage>1</fpage>
                <pub-id pub-id-type="pmid">18171466</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.choi.2006.1563">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Inherited erythermalgia: limb pain from an S4 charge-neutral Na channelopathy.</article-title>
                <source>Neurology</source>
                <volume>67</volume>
                <fpage>1563</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16988069</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.choi.2009.383">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyrrell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Mexiletine-responsive erythromelalgia due to a new Na<sub>v</sub>1.7 mutation showing use-dependent current fall-off.</article-title>
                <source>Exp Neurol</source>
                <volume>216</volume>
                <fpage>383</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19162012</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.choi.2010.1823">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foster</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leffler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyrrell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Te Morsche</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eastman</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huehne</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nau</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drenth</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Alternative splicing may contribute to time-dependent manifestation of inherited erythromelalgia.</article-title>
                <source>Brain</source>
                <volume>133</volume>
                <fpage>1823</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">20478850</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.cohen.2000.841">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Erythromelalgia: new theories and new therapies.</article-title>
                <source>J Am Acad Dermatol</source>
                <volume>43</volume>
                <fpage>841</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11050591</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.cohen.2002.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>High-dose oral magnesium treatment of chronic, intractable erythromelalgia.</article-title>
                <source>Ann Pharmacother</source>
                <volume>36</volume>
                <fpage>255</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">11847944</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.cox.2006.894">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reimann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholas</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thornton</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Springell</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karbani</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jafri</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raashid</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Gazali</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamamy</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valente</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McHale</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gribble</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woods</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>An SCN9A channelopathy causes congenital inability to experience pain.</article-title>
                <source>Nature</source>
                <volume>444</volume>
                <fpage>894</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17167479</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.cummins.2004.8232">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cummins</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy.</article-title>
                <source>J Neurosci</source>
                <volume>24</volume>
                <fpage>8232</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15385606</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.cummins.1998.9607">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cummins</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howe</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel.</article-title>
                <source>J Neurosci</source>
                <volume>18</volume>
                <fpage>9607</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">9822722</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.davis.2005.1320">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandroni</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Lidocaine patch for pain of erythromelalgia: follow-up of 34 patients.</article-title>
                <source>Arch Dermatol</source>
                <volume>141</volume>
                <fpage>1320</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">16230578</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.davis.2000.330">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Fallon</surname>
                    <given-names>WM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>RS</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Rooke</surname>
                    <given-names>TW</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Natural history of erythromelalgia: presentation and outcome in 168 patients.</article-title>
                <source>Arch Dermatol</source>
                <volume>136</volume>
                <fpage>330</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10724194</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.davis.2003.1337">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandroni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rooke</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Low</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Erythromelalgia: vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgia.</article-title>
                <source>Arch Dermatol</source>
                <volume>139</volume>
                <fpage>1337</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">14568838</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.dellera.2004.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dell'era</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corona</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lapidari</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capanna</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Severgnini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costantini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bardare</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carnelli</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Magnesium: a decisive therapy for erythromelalgia.</article-title>
                <source>Ital J Ped</source>
                <volume>30</volume>
                <fpage>125</fpage>
                <lpage>6</lpage>
              </element-citation>
            </ref>
            <ref id="etha.REF.delye.2005.e404">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Delye</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagae</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermylen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nuttin</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Thalamic stimulation as a treatment for primary erythromelalgia: technical case report.</article-title>
                <source>Neurosurgery</source>
                <volume>57</volume>
                <fpage>E404</fpage>
                <pub-id pub-id-type="pmid">16234658</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.diaz.2005.427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Diaz</surname>
                    <given-names>JH</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Syndromic diagnosis and management of confirmed mushroom poisonings.</article-title>
                <source>Crit Care Med</source>
                <volume>33</volume>
                <fpage>427</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">15699849</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.dibhajj.2007.555">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cummins</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>From genes to pain: Nav1.7 and human pain disorders.</article-title>
                <source>Trends Neurosci</source>
                <volume>30</volume>
                <fpage>555</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">17950472</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.dibhajj.2005.1847">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rush</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cummins</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hisama</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Novella</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyrrell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marshall</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons.</article-title>
                <source>Brain</source>
                <volume>128</volume>
                <fpage>1847</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">15958509</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.dibhajj.2010.325">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cummins</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Sodium Channels in Normal and Pathological Pain.</article-title>
                <source>Annu Rev Neurosci</source>
                <volume>33</volume>
                <fpage>325</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">20367448</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.dibhajj.2013.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>The Na<sub>V</sub>1.7 sodium channel: from molecule to man.</article-title>
                <source>Nat Rev Neurosci</source>
                <volume>14</volume>
                <fpage>49</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">23232607</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.dicaudo.2004.621">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>DiCaudo</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelley</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Alleviation of erythromelalgia with venlafaxine.</article-title>
                <source>Arch Dermatol</source>
                <volume>140</volume>
                <fpage>621</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">15148116</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.djouhri.2003.565">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Djouhri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newton</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levinson</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carruthers</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lawson</surname>
                    <given-names>SN</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Sensory and electrophysiological properties of guinea-pig sensory neurones expressing Nav 1.7 (PN1) Na+ channel alpha subunit protein.</article-title>
                <source>J Physiol (Lond)</source>
                <volume>546</volume>
                <fpage>565</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">12527742</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.drenth.1994.393">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Drenth</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michiels</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Erythromelalgia and erythermalgia: diagnostic differentiation.</article-title>
                <source>Int J Dermatol</source>
                <volume>33</volume>
                <fpage>393</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8056469</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.drenth.2001.1277">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Drenth</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finley</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breedveld</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Testers</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michiels</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillet</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taieb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirby</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heutink</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The primary erythermalgia-susceptibility gene is located on chromosome 2q31-32.</article-title>
                <source>Am J Hum Genet</source>
                <volume>68</volume>
                <fpage>1277</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">11283792</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.drenth.2005.1333">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Drenth</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>te Morsche</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillet</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taieb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirby</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>JB</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage-gated sodium channels.</article-title>
                <source>J Invest Dermatol</source>
                <volume>124</volume>
                <fpage>1333</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15955112</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.drenth.2008.320">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Drenth</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Te Morsche</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansour</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortimer</surname>
                    <given-names>PS</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Primary erythermalgia as a sodium channelopathy: screening for SCN9A mutations: exclusions of a causal role of SCN10A and SCN11A.</article-title>
                <source>Arch Dermatol</source>
                <volume>144</volume>
                <fpage>320</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">18347287</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.drenth.2007.3603">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Drenth</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders.</article-title>
                <source>J Clin Invest</source>
                <volume>117</volume>
                <fpage>3603</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18060017</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.estacion.2013.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Estacion</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyrrell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>A new Na<sub>v</sub>1.7 mutation in an erythromelalgia patient.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>432</volume>
                <fpage>99</fpage>
                <lpage>104</lpage>
                <pub-id pub-id-type="pmid">23376079</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.faber.2012.26">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Faber</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoeijmakers</surname>
                    <given-names>JGJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahn</surname>
                    <given-names>H-S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>J-S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estacion</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lauria</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanhoutte</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerrits</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drenth</surname>
                    <given-names>JPH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merkles</surname>
                    <given-names>IJS</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Gain of function Nav1.7 mutations in idiopathic small fiber neuropathy.</article-title>
                <source>Ann Neurol</source>
                <volume>71</volume>
                <fpage>26</fpage>
                <lpage>39</lpage>
                <pub-id pub-id-type="pmid">21698661</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.fertleman.2006.1294">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fertleman</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrie</surname>
                    <given-names>CD</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>What's in a name--familial rectal pain syndrome becomes paroxysmal extreme pain disorder.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>77</volume>
                <fpage>1294</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17043302</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.fertleman.2006.767">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fertleman</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parker</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moffatt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elmslie</surname>
                    <given-names>FV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abrahamsen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ostman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klugbauer</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wood</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardiner</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rees</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes.</article-title>
                <source>Neuron</source>
                <volume>52</volume>
                <fpage>767</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">17145499</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.fertleman.2007.586">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fertleman</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrie</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aicardi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bednarek</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eeg-Olofsson</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elmslie</surname>
                    <given-names>FV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griesemer</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goutieres</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirkpatrick</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malmros</surname>
                    <given-names>IN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollitzer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossiter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roulet-Perez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schubert</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>VV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Testard</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephenson</surname>
                    <given-names>JB</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Paroxysmal extreme pain disorder (previously familial rectal pain syndrome).</article-title>
                <source>Neurology</source>
                <volume>69</volume>
                <fpage>586</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">17679678</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.fertleman.2004">
              <mixed-citation publication-type="confproc">Fertleman CR, Rees M, Parker KA, Barlow E, Gardiner RM. Identification of the gene underlying an inherited disorder of pain sensation. Abstract 197. Toronto, Canada: American Society of Human Genetics Annual Meeting; 2004.</mixed-citation>
            </ref>
            <ref id="etha.REF.fischer.2009.733">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>TZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilmore</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estacion</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eastman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melanson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia.</article-title>
                <source>Ann Neurol</source>
                <volume>65</volume>
                <fpage>733</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">19557861</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.goldberg.2007.311">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>YP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacFarlane</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dube</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mattice</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fraser</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hossain</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pape</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payne</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radomski</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donaldson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ives</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Younghusband</surname>
                    <given-names>HB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duff</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boltshauser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grinspan</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimon</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sibley</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andria</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toscano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerdraon</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowsher</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pimstone</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samuels</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherrington</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayden</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations.</article-title>
                <source>Clin Genet</source>
                <volume>71</volume>
                <fpage>311</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17470132</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.goldberg.2012.80">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>YP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Price</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Namderi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamers</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winters</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Price</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verschoof</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherirington</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pimstone</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayden</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Treatment of Nav1.7-mediated paiin in inherited erythromelalgia using a novel sodium channel blocker.</article-title>
                <source>Pain</source>
                <volume>153</volume>
                <fpage>80</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22035805</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.han.2009.1711">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eastman</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyrrell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/19369487">Early- and late-onset inherited erythromelalgia: genotype-phenotype correlation.</ext-link>
                <source>Brain.</source>
                <year>2009</year>
                <volume>132</volume>
                <fpage>1711</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">19369487</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.han.2006.553">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rush</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyrrell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Sporadic onset of erythermalgia: A gain-of-function mutation in Na(v)1.7.</article-title>
                <source>Ann Neurol</source>
                <volume>59</volume>
                <fpage>553</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16392115</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.harty.2006.12566">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harty</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyrrell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blackman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hisama</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rose</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Na(V)1.7 mutant A863P in erythromelalgia: effects of altered activation and steady-state inactivation on excitability of nociceptive dorsal root ganglion neurons.</article-title>
                <source>J Neurosci</source>
                <volume>26</volume>
                <fpage>12566</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">17135418</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.kuhnert.1999.1447">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kuhnert</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Lidocaine and mexiletine therapy for erythromelalgia.</article-title>
                <source>Arch Dermatol</source>
                <volume>135</volume>
                <fpage>1447</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10606048</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.kvernebo.1998.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kvernebo</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Erythromelalgia: a condition caused by microvascular arteriovenous shunting.</article-title>
                <source>Vasa Suppl</source>
                <volume>51</volume>
                <fpage>1</fpage>
                <lpage>40</lpage>
              </element-citation>
            </ref>
            <ref id="etha.REF.lampert.2006.36029">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lampert</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyrrell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Size matters: Erythromelalgia mutation S241T in Nav1.7 alters channel gating.</article-title>
                <source>J Biol Chem</source>
                <volume>281</volume>
                <fpage>36029</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">17008310</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.lee.2007.210">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsieh</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephenson</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>CC</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Characterization of a familial case with primary erythromelalgia from Taiwan.</article-title>
                <source>J Neurol</source>
                <volume>254</volume>
                <fpage>210</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">17294067</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.littleford.1999.507">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Littleford</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belch</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Impaired skin vasomotor reflexes in patients with erythromelalgia.</article-title>
                <source>Clin Sci (Lond)</source>
                <volume>96</volume>
                <fpage>507</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">10209083</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.mccarthy.2002.1245">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McCarthy</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eichelberger</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skipworth</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danielson</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Erythromelalgia due to essential thrombocythemia.</article-title>
                <source>Transfusion</source>
                <volume>42</volume>
                <fpage>1245</fpage>
                <pub-id pub-id-type="pmid">12423504</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.michiels.2005.1587">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Michiels</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>te Morsche</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drenth</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7.</article-title>
                <source>Arch Neurol</source>
                <volume>62</volume>
                <fpage>1587</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">16216943</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.mitchell.1878.2">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1878</year>
                <article-title>On a rare vaso-motor neurosis of the extremities, and on the maladies with which it may be confounded.</article-title>
                <source>Am J Med Sci</source>
                <volume>41</volume>
                <fpage>2</fpage>
                <lpage>36</lpage>
              </element-citation>
            </ref>
            <ref id="etha.REF.mork.2000a.643">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mork</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asker</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salerud</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kvernebo</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2000a</year>
                <article-title>Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia.</article-title>
                <source>J Invest Dermatol</source>
                <volume>114</volume>
                <fpage>643</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10733667</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.mork.1999.394">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mork</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalgaard</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kvernebo</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Erythromelalgia as a paraneoplastic syndrome in a patient with abdominal cancer.</article-title>
                <source>Acta Derm Venereol</source>
                <volume>79</volume>
                <fpage>394</fpage>
                <pub-id pub-id-type="pmid">10494725</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.mork.2000b.498">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mork</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalgaard</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myrvang</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kvernebo</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2000b</year>
                <article-title>Erythromelalgia in a patient with AIDS.</article-title>
                <source>J Eur Acad Dermatol Venereol</source>
                <volume>14</volume>
                <fpage>498</fpage>
                <lpage>500</lpage>
                <pub-id pub-id-type="pmid">11444274</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.mork.2002.949">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mork</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kvernebo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asker</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salerud</surname>
                    <given-names>EG</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Reduced skin capillary density during attacks of erythromelalgia implies arteriovenous shunting as pathogenetic mechanism.</article-title>
                <source>J Invest Dermatol</source>
                <volume>119</volume>
                <fpage>949</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">12406343</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.mork.2004.587">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mork</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salerud</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asker</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kvernebo</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The prostaglandin E1 analog misoprostol reduces symptoms and microvascular arteriovenous shunting in erythromelalgia-a double-blind, crossover, placebo-compared study.</article-title>
                <source>J Invest Dermatol</source>
                <volume>122</volume>
                <fpage>587</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">15086539</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.nathan.2005.e504">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nathan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rose</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guite</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hehir</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milovcich</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment.</article-title>
                <source>Pediatrics</source>
                <volume>115</volume>
                <fpage>e504</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15741349</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.natkunarajah.2009.e640">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Natkunarajah</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atherton</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elmslie</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansour</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortimer</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.</article-title>
                <source>Clin Exp Dermatol</source>
                <volume>34</volume>
                <fpage>e640</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">19549232</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.orstavik.2004.531">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Orstavik</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mork</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kvernebo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jorum</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Pain in primary erythromelalgia--a neuropathic component?</article-title>
                <source>Pain</source>
                <volume>110</volume>
                <fpage>531</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15288393</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.orstavik.2003.567">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Orstavik</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weidner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmelz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilliges</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jorum</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Handwerker</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torebjork</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Pathological C-fibres in patients with a chronic painful condition.</article-title>
                <source>Brain</source>
                <volume>126</volume>
                <fpage>567</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">12566278</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.raymond.2004.46234">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>CK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garrett-Engele</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armour</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kan</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsinoremas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Expression of alternatively spliced sodium channel alpha-subunit genes. Unique splicing patterns are observed in dorsal root ganglia.</article-title>
                <source>J Biol Chem</source>
                <volume>279</volume>
                <fpage>46234</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">15302875</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.rush.2006.8245">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rush</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cummins</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>103</volume>
                <fpage>8245</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">16702558</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.samuels.2008.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Samuels</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>te Morsche</surname>
                    <given-names>RHM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drenth</surname>
                    <given-names>JPH</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Compound heterozygosity in sodium channel Nav1.7 in a family with hereditary erythermalgia.</article-title>
                <source>Mol Pain</source>
                <volume>4</volume>
                <fpage>21</fpage>
                <pub-id pub-id-type="pmid">18518989</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.sandroni.2006.283">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sandroni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Combination gel of 1% amitriptyline and 0.5% ketamine to treat refractory erythromelalgia pain: a new treatment option?</article-title>
                <source>Arch Dermatol</source>
                <volume>142</volume>
                <fpage>283</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16549702</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.sano.2003.816">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itami</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshikawa</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Treatment of primary erythromelalgia with cyclosporine.</article-title>
                <source>N Engl J Med</source>
                <volume>349</volume>
                <fpage>816</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12930941</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.schott.2001.291">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schott</surname>
                    <given-names>GD</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Reflex sympathetic dystrophy.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>71</volume>
                <fpage>291</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11511699</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.sheets.2007.1019">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sheets</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson Ii</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cummins</surname>
                    <given-names>TR</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity.</article-title>
                <source>J Physiol (Lond)</source>
                <volume>581</volume>
                <fpage>1019</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">17430993</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.singh.2009.e1000649">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pappas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahle</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>LRF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pruess</surname>
                    <given-names>TH.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dixon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurnett</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peiffer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>HS.</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filloux</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppert</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome.</article-title>
                <source>PLoS Genet.</source>
                <volume>5</volume>
                <fpage>e1000649</fpage>
                <pub-id pub-id-type="pmid">19763161</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.takahashi.2007.157">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitoh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoshino</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mimaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokoyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takamizawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizuguchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>ZM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A case of primary erythermalgia, wintry hypothermia and encephalopathy.</article-title>
                <source>Neuropediatrics</source>
                <volume>38</volume>
                <fpage>157</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17985268</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.thami.2003.910">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thami</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhalla</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Erythromelalgia induced by possible calcium channel blockade by ciclosporin.</article-title>
                <source>BMJ</source>
                <volume>326</volume>
                <fpage>910</fpage>
                <pub-id pub-id-type="pmid">12714471</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.waxman.2005a.785">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                </person-group>
                <year>2005a</year>
                <article-title>Erythromelalgia: a hereditary pain syndrome enters the molecular era.</article-title>
                <source>Ann Neurol</source>
                <volume>57</volume>
                <fpage>785</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15929046</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.waxman.2005b.555">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Waxman</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dib-Hajj</surname>
                    <given-names>SD</given-names>
                  </name>
                </person-group>
                <year>2005b</year>
                <article-title>Erythermalgia: molecular basis for an inherited pain syndrome.</article-title>
                <source>Trends Mol Med</source>
                <volume>11</volume>
                <fpage>555</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">16278094</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.yang.2004.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>171</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">14985375</pub-id>
              </element-citation>
            </ref>
            <ref id="etha.REF.yosipovitch.1999.473">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yosipovitch</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rechavia</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feinmesser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Adverse cutaneous reactions to ticlopidine in patients with coronary stents.</article-title>
                <source>J Am Acad Dermatol</source>
                <volume>41</volume>
                <fpage>473</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10459126</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="etha.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="etha.Acknowledgments">
          <title>Acknowledgments</title>
          <p>This work is supported in part by a gift from the Erythromelalgia Association.</p>
        </sec>
        <sec id="etha.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>15 August 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>25 September 2008 (cd) Revision: prenatal testing available</p>
            </list-item>
            <list-item>
              <p>26 August 2008 (cg) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>28 March 2007 (fmh) Revision: sequence analysis for <italic toggle="yes">SCN9A</italic> clinically available</p>
            </list-item>
            <list-item>
              <p>18 January 2007 (cd) Revision: mutations in <italic toggle="yes">SCN9A</italic> resulting in loss of function of sodium channel protein type 9 subunit alpha cause channelopathy-associated insensitivity to pain.</p>
            </list-item>
            <list-item>
              <p>5 May 2006 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>2 August 2005 (fmh) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="etha.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Red and swollen feet of an individual with <italic toggle="yes">SCN9A</italic>-related IEM</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="etha-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="etha.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>The exon/intron boundary in the genomic sequence of <italic toggle="yes">SCN9A</italic></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="etha-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
